Tyra Biosciences Stock Statistic Functions Beta

TYRA Stock  USD 36.22  0.22  0.61%   
Use the statistic functions workspace to apply Beta function and other studies to Tyra Biosciences. The focus on statistical functions describing dispersion and variability helps organize trend, volatility, and risk context for Tyra Biosciences.Enter Time Period to start the analysis.

The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Tyra Biosciences correlated with the market. If Beta is less than 0 Tyra Biosciences generally moves in the opposite direction as compared to the market. If Tyra Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tyra Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tyra Biosciences is generally in the same direction as the market. If Beta > 1 Tyra Biosciences moves generally in the same direction as, but more than the movement of the benchmark.

Tyra Biosciences Technical Analysis Modules

Most technical analysis of Tyra Biosciences help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tyra from various momentum indicators to cycle indicators. When you analyze Tyra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California. Tyra Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 25 people. As a mid-cap equity, Tyra Biosciences is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 7.49. Tyra Biosciences has a market cap of 1.94 B, ROE of -39.83%.

Methodology

Unless otherwise specified, financial data for Tyra Biosciences is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Tyra (USA Stocks:TYRA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Tyra Biosciences is covered by 11 analysts. 5 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Evercore ISI, Morgan Stanley, BMO Capital Markets, Oppenheimer & Co., Guggenheim Securities, HSBC Global Research, Raymond James, Bernstein Research, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Become your own money manager

Tracking Tyra Biosciences inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 20 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Social Domain Idea
Social Domain
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Macroaxis Picks Idea
Macroaxis Picks
Invested few shares
Data Storage Idea
Data Storage
Invested few shares
Impulse Idea
Impulse
Invested over 200 shares
FinTech Idea
FinTech
Invested over 20 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares

More Resources for Tyra Stock Analysis

Reviewing Tyra Biosciences commonly begins with financial statements and performance trends. Financial ratios provide context for profitability, efficiency, and growth trends. Selected reports below provide context for Tyra Stock:
Tyra Biosciences has a market cap of 1.94 B, ROE of -39.83%. See World Market Map for portfolio-level analysis. This suggests a position in Tyra Biosciences within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Our How to Buy Tyra Stock guide explains the steps to invest in Tyra Biosciences stock.
Analysis related to Tyra Biosciences should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
 Earnings Share
-2.01
 Return On Assets
-0.26
 Return On Equity
-0.40
Investors evaluate Tyra Biosciences using market value and book value, each describing different facets of the business. Tyra Biosciences' market capitalization is 1.94 B. With a P/B ratio of 7.49, the market values Tyra Biosciences well above its book equity. Enterprise value stands at 1.69 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Tyra Biosciences differs from its quoted price, since each reflects a different lens. For Tyra Biosciences, key inputs include a P/B ratio of 7.49, and ROE of -39.83%. Trading price represents the transaction level agreed by market participants.